A recent study from The New England Journal of Medicine (NEJM) reveals a new system that has “improved glycemic outcomes in patients with type 1 diabetes.” The technology in question is a closed-loop system that automates the patient’s insulin delivery.
The study was conducted over a 6-month period with 168 patients between ages 14 and 71 years – 112 used the closed-loop system while the remaining 56 were the control group. The results revealed that the closed-loop system provided patients with a “greater percentage of time spent in the target glycemic range” than those who used “a sensor-augmented insulin pump.”
This research is important for nurses and other healthcare practitioners who are at the forefront of diabetes care.
Please visit NEJM to read more about the study.
Source:
1 Comment.
Great post! Thank you for the insightful article. I would like to include a little bit more information that long-term hyperglycemia during diabetes causes chronic damage and dysfunction of various tissues, especially the eyes, kidneys, heart, blood vessels, and nerves.